The Ramaciotti Foundations are a philanthropic organisation that provides financial support to medical research in Australia.
The Ramaciotti Medal for Excellence is awarded annually to an Australian researcher who has made a significant contribution to biomedical research in Australia. The award is accompanied by a medal and a cash prize of AUD $50,000. The recipient of the award is selected by a panel of experts in biomedical research, who evaluate the nominees based on the quality and impact of their research.
The Ramaciotti Medal for Excellence is considered one of the most prestigious awards in biomedical research in Australia and is highly sought after by researchers in the field.
In 2022, Professor Matthew Kiernan was the recipient of the Ramaciotti Medal for Excellence and the associated $50,000 award. Professor Kiernan is considered one of Australia’s most prominent clinical neurologists and neuroscientists and has received the Ramaciotti Medal in recognition of his extensive research into neurodegenerative disease including dementia and motor neurone disease (amyotrophic lateral sclerosis; MND/ALS).
His extensive record of research into the pathophysiology of MND has resulted in breakthroughs that have changed the management of the disease by physicians worldwide. His research has closed the loop from bench to bedside with technique developments and scientific discoveries translating into greater understanding of the disease and improved patient management.
Professor Kiernan is the Bushell Chair of Neurology and Co-Director of the Brain and Mind Centre at The University of Sydney. He is Professor of Neurology and Staff Specialist at the Royal Prince Alfred Hospital. His work has led to appointments including Chair of the World Federation of Neurology – Motor Neurone Speciality Disease Group, and international recognition through The Forbes Norris Award of the International Alliance of ALS/MND Associations and most recently the Sheila Essey Award of the American Academy of Neurology for significant research contributions in the search for causes, prevention, and cure of ALS.
Australian Health Journal spoke with Professor Kiernan to hear about his journey in medicine and science to try and uncover and understand diseases and his generosity of spirit to pass on what he has learnt.
You Might also like
-
Alfred Hospital leading in pharmacy services for critically unwell patients
Cristina Roman, is the Lead Pharmacist at Alfred Emergency Trauma Centre. In her 12 years working in the Emergency Department, Cristina has established pharmacy services, and filled gaps in patient care with new models of care.
One of those models of care adopted by the US and other countries, is involving pharmacists for critically unwell patients that present to the emergency department.
Australian Health Journal spoke with Cristina Roman and Lisa Bremner, Advanced Training Resident Pharmacist at Alfred Hospital Emergency Trauma Centre.
-
Improving access to osteopathic services and integrated care models
The Chief Executive Officer of Osteopathy Australia, Antony Nicholas spoke with Australian Health Journal about:
– Involvement in the Strengthening Medicare Task Force
– The unique skills osteopaths have that can address the chronic disease burden
– Current workforce issues around osteopaths and if enough are coming through via student placements
– How uploading data to My Health Record by osteopaths could assist team-based care of patients
– How the value of osteopaths in Residential Aged Care Facilities (RACFs) could be better understood and better access for residents
– The recommendations around aged care access to allied health services, including osteopathy
– The recommendations around consumer access to osteopaths and GP referrals
– Other osteopathy recommendations in the upcoming Federal BudgetIn the lead up to the Australian Federal Budget in May 2023, Australian Health Journal reached out to peak health industry bodies to hear about their priorities, either noted in pre-budget submissions lodged with Federal Government in January 2023 or in recent forums such as the Strengthening Medicare Taskforce.
-
Building capacity with job-ready clinical trial interns
The Victorian Comprehensive Cancer Centre Alliance, or VCCC Alliance for short, is a Victorian partnership of 10 research, academic and clinical institutions looking at improving cancer outcomes for patients.
The VCCC Alliance SKILLED clinical trial internships program is a pathway for scientists to build role-specific clinical trial knowledge, experience and in a clinical trials unit through theoretical and on-the-job training. The internship program is a 40 week intensive program to get science student interns job ready for clinical trial assistant and study coordinator internship roles.